Table 1 (abstract P082). Baseline clinical and biomarker levels
From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)
Parameter | Responders (n=20) | Non-responders (n=14) | p value* |
|---|---|---|---|
Age at onset (months), median (IQR) | 72(36,132) | 87(30,108) | 0.84 |
Mean delay in diagnosis (months), median (IQR) | 21(4,59) | 30(18,54) | 0.326 |
JIA Subcategory, n | |||
 SJIA | 3 | 0 | 0.179 |
 Oligoarticular | 3 | 6 | |
 Polyarticular (RF+) | 0 | 1 | |
 Polyarticular (RF-) | 6 | 2 | |
 Entesitis related arthritis | 7 | 5 | |
Serum MRP 8/14 (pg/ml), median (IQR) | 117.7(87.4,155.8) | 78.8(59,118) | 0.027 |
Serum IL-6 (pg/ml), median (IQR) | 20.3(16.5,23.7) | 14(12.2,18.2) | 0.019 |
Serum IL-2 (pg/ml), median (IQR) | 126.5(45.9,134.5) | 43(31.9,81.9) | 0.21 |
Serum TNFa (pg/ml), median (IQR) | 30.7(27.4,32.9) | 32.4(37,28.3) | 0.43 |
Serum IL-12 (pg/ml), median (IQR) | 48.4(38.3,57.2) | 45.5(34,82) | 0.83 |